RenovoRx, Inc. (RNXT) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts RNXT Hot Sheet
Join SI Premium – FREE
RenovoRx, Inc. (NASDAQ: RNXT) reported Q2 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $40 thousand versus the consensus estimate of $287.97 thousand.
For earnings history and earnings-related data on RenovoRx, Inc. (RNXT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic plans IPO potentially exceeding SpaceX's $86B record - Bloomberg
- Bessent on Iran: maximum economic pressure means likely not a kinetic restart
- ScanSource (SCSC) Tops Q4 EPS by 32c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
